Gabapentin as a possible treatment of behavioral alterations in Alzheimer disease (AD) patients.

R Moretti, P Torre, R M Antonello, G Cazzato

Journal: European journal of neurology 2001;8(5):501-2

PMID: 11554917

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

DOI: 10.1046/j.1468-1331.2001.00225.x

Link outs

Free resources

Medical:

https://medlineplus.gov/alzheimersdisease.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...
https://doi.org/10.1046/j.1468-1331.2001.00225.x

MeSH Terms: Acetates, Aged, Alzheimer Disease, Amines, Behavior, Cyclohexanecarboxylic Acids, Excitatory Amino Acid Agonists, Female, Gabapentin, Humans, Male, gamma-Aminobutyric Acid

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.